Sugistran 12.5 mg Capsule: Specialized Precision Dosing for Targeted Oncology
Are you searching for a trusted Sugistran 12.5 mg capsule exporter from India? Ernest Impex, a key entity within the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced oncology therapies. We facilitate a highly secure, temperature-controlled supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical Sunitinib formulations reach global clinics with 100% pharmaceutical integrity.
Detailed Product Overview: What is Sugistran 12.5 mg?
Sugistran 12.5 mg Capsule is an oral multi-targeted tyrosine kinase inhibitor (TKI) containing the active ingredient Sunitinib. Manufactured by Celon Laboratories Pvt. Ltd., a leader in specialty pharmaceuticals, the 12.5 mg strength is a critical titration dose. It allows oncologists to precisely tailor treatment regimens, optimizing therapeutic outcomes while managing patient-specific side effects.
For international B2B procurement, Sugistran 12.5 mg is an essential asset for hospital pharmacies and oncology centers managing advanced solid tumors.
Primary Therapeutic Indications
Sugistran 12.5 mg is clinically utilized globally for the following:
Metastatic Renal Cell Carcinoma (mRCC): A frontline treatment for advanced kidney cancer.
Gastrointestinal Stromal Tumor (GIST): For patients who have progressed on or are intolerant to Imatinib Mesylate.
Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable locally advanced or metastatic disease.
Mechanism of Action: Multi-Pathway Signal Disruption
Sugistran 12.5 mg works by interfering with the biological signals that cancer cells require to grow and proliferate:
VEGF Receptor Inhibition: It targets all receptors for vascular endothelial growth factors (VEGFR-1, -2, -3). This prevents angiogenesis, effectively "starving" the tumor of the blood supply it needs to grow.
PDGF Receptor Blockade: By inhibiting Platelet-Derived Growth Factor Receptors (PDGFR-Ξ± and -Ξ²), it disrupts the communication between cancer cells and their supporting environment.
KIT & FLT3 Targeting: It binds to the stem cell factor receptor (KIT) and FLT3, interrupting the internal signals that drive rapid cell division in gastrointestinal and hematological malignancies.
Precision Titration: The 12.5 mg strength is essential for dose reduction strategies, ensuring patients can remain on therapy longer with manageable toxicity.
Administration and Clinical Safety
Dosage Protocol: Typically taken once daily. For RCC and GIST, the standard schedule is 4 weeks of treatment followed by a 2-week rest period.
Storage: Store at room temperature (below 30Β°C). Keep capsules in their original container to protect from light and moisture.
Key Monitoring Parameters:
Hypertension: Blood pressure must be monitored regularly as Sunitinib is known to cause significant elevations.
Cardiac Function: Periodic assessment of left ventricular ejection fraction (LVEF) is recommended.
Thyroid Function: Routine screening for hypothyroidism is standard clinical practice.
Liver Health: Periodic liver function tests (LFTs) are necessary to ensure systemic safety.
Why Source Sugistran 12.5 mg from Ernest Impex?
Authentic Celon Oncology Exporter: Direct access to genuine Sugistran inventory ensures 100% authenticity and highly competitive wholesale pricing for global markets.
Global Distribution Authority: We specialize in the complex documentation and specialized logistics required for Washington, London, Bangkok, Canberra, Singapore, and Kingston.
Regulatory Transparency: We provide all essential B2B documentation, including GMP compliance certificates, batch-specific COAs, and international export permits.
Supply Chain Resilience: In 2026, we prioritize digital traceability and consistent bulk fulfillment for hospital networks and regional distributors.
π Contact Ernest Impex β Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
π Websites:
π§ Email:
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 93599 02383